About Parse Biosciences
Parse Biosciences is a company based in Seattle (United States) founded in 2018 by Geoff Krummel, Charlie Roco, and Alex Rosenberg.. Parse Biosciences has raised $100.26 million across 7 funding rounds from investors including Marshall Wace, Janus Henderson Investors and Horizon Tech Finance. Parse Biosciences has completed 1 acquisition, including Biomage. Parse Biosciences operates in a competitive market with competitors including Neogen, Sino Biological, Qiagen, Biofidelity and GenScript, among others.
- Headquarter Seattle, United States
- Founders Geoff Krummel, Charlie Roco, Alex Rosenberg
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$100.26 M (USD)
in 7 rounds
-
Latest Funding Round
-
Investors
Marshall Wace
& 8 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Parse Biosciences
Parse Biosciences has successfully raised a total of $100.26M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Last Round
-
First Round
First Round
(17 Oct 2018)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Debt – Conventional - Parse Biosciences | Valuation |
investors |
|
| Dec, 2023 | Amount | Series C - Parse Biosciences | Valuation | Soleus Capital | |
| Feb, 2022 | Amount | Series B - Parse Biosciences | Valuation | Janus Henderson Investors , Marshall Wace |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Parse Biosciences
Parse Biosciences has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Marshall Wace, Janus Henderson Investors and Horizon Tech Finance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Multiple sectors are targeted for venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Parse Biosciences
Parse Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Biomage. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of a cloud-based cell and genomic sequence analysis platform for researchers
|
2019 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Parse Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Parse Biosciences Comparisons
Competitors of Parse Biosciences
Parse Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neogen, Sino Biological, Qiagen, Biofidelity and GenScript, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Parse Biosciences
Frequently Asked Questions about Parse Biosciences
When was Parse Biosciences founded?
Parse Biosciences was founded in 2018.
Where is Parse Biosciences located?
Parse Biosciences is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Who is the current CEO of Parse Biosciences?
Alex Rosenberg is the current CEO of Parse Biosciences. They have also founded this company.
Is Parse Biosciences a funded company?
Parse Biosciences is a funded company, having raised a total of $100.26M across 7 funding rounds to date. The company's 1st funding round was a Series B of $41.5M, raised on Oct 17, 2018.
What does Parse Biosciences do?
Parse Biosciences was founded in 2018 in Seattle, United States, within the biotechnology sector. RNA-sequencing solution-based kits are developed for transcriptome analysis of health data. Solutions are provided to enable researchers to process fixed samples from various collection dates in one experiment, with oversight on sample handling to minimize errors. Barcoding is applied to label single-cell or single-nucleus suspensions for sequencing, complemented by data analysis tools.
Who are the top competitors of Parse Biosciences?
Parse Biosciences's top competitors include Neogen, Sino Biological and Qiagen.
How many acquisitions has Parse Biosciences made?
Parse Biosciences has made 1 acquisition, including Biomage.
Who are Parse Biosciences's investors?
Parse Biosciences has 9 investors. Key investors include Marshall Wace, Janus Henderson Investors, Horizon Tech Finance, Soleus Capital, and Bioeconomy Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.